153 related articles for article (PubMed ID: 8121319)
1. Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment.
Bachir D; Maurel A; Beuzard Y; Razavian M; Kraiem A; Portos JL; Galacteros F
Microvasc Res; 1993 Nov; 46(3):359-73. PubMed ID: 8121319
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of laser Doppler flux metering, bulbar conjunctival angioscopy, and nail fold capillaroscopy in sickle cell disease.
Bachir D; Maurel A; Portos JL; Galacteros F
Microvasc Res; 1993 Jan; 45(1):20-32. PubMed ID: 8479339
[TBL] [Abstract][Full Text] [Related]
3. [Action of Buflomedil on the cutaneous microcirculation studies by a cold provocation test. Multicenter, double-blind, placebo controlled trial].
Maurel A; Betrancourt JC; Van Frenkel R; Thuillez C
J Mal Vasc; 1995; 20(2):127-33. PubMed ID: 7650439
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
Van den Brande P; Maurel A
Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
[TBL] [Abstract][Full Text] [Related]
5. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
; Leizorovicz A; Becker F
Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
[TBL] [Abstract][Full Text] [Related]
6. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
[TBL] [Abstract][Full Text] [Related]
7. Effects of buflomedil on skin blood flow in patients with type 2 diabetes mellitus without overt micro- or macroangiopathy.
Tsantilas D; Hatzitolios AI; Tziomalos K; Karamitsos D; Papadimitriou D
Int Angiol; 2011 Apr; 30(2):164-71. PubMed ID: 21427654
[TBL] [Abstract][Full Text] [Related]
8. [Effects of buflomedil and naftidrofuryl on the human cochlear microcirculation measured by laser-Doppler].
Preckel MP; Dégoute CS; Dubreuil C; Boulud B; Tassard AM; Banssillon V
Rev Laryngol Otol Rhinol (Bord); 1995; 116(1):69-72. PubMed ID: 7644852
[TBL] [Abstract][Full Text] [Related]
9. [Effect of buflomedil on microcirculation of the skin in acral gangrene].
Fagrell B; Hermansson IL
Fortschr Med; 1985 Jan; 103(1-2):23-7. PubMed ID: 3882535
[No Abstract] [Full Text] [Related]
10. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
[TBL] [Abstract][Full Text] [Related]
11. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
[TBL] [Abstract][Full Text] [Related]
12. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
14. Short-range intermittent claudication and rest pain: microcirculatory effects of pentoxifylline in a randomized, controlled trial.
Incandela L; De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Geroulakos G; Ramaswami G
Angiology; 2002; 53 Suppl 1():S27-30. PubMed ID: 11865832
[TBL] [Abstract][Full Text] [Related]
15. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease.
Kutlar A; Ataga KI; McMahon L; Howard J; Galacteros F; Hagar W; Vichinsky E; Cheung AT; Matsui N; Embury SH
Am J Hematol; 2012 May; 87(5):536-9. PubMed ID: 22488107
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous ulcers with pentoxifylline: a 12-month, double-blind, placebo controlled trial. Microcirculation and healing.
De Sanctis MT; Belcaro G; Cesarone MR; Ippolito E; Nicolaides AN; Incandela L; Geroulakos G
Angiology; 2002; 53 Suppl 1():S49-51. PubMed ID: 11865837
[TBL] [Abstract][Full Text] [Related]
17. Effects of N-acetylcysteine on dense cell formation in sickle cell disease.
Pace BS; Shartava A; Pack-Mabien A; Mulekar M; Ardia A; Goodman SR
Am J Hematol; 2003 May; 73(1):26-32. PubMed ID: 12701116
[TBL] [Abstract][Full Text] [Related]
18. Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil.
Jacobs MJ; Lemmens HA
Int J Microcirc Clin Exp; 1985; 4(1):63-8. PubMed ID: 3886577
[TBL] [Abstract][Full Text] [Related]
19. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
[TBL] [Abstract][Full Text] [Related]
20. Multicentre clinical placebo-controlled study with buflomedil in the treatment of mild dementia of vascular origin.
Cucinotta D; Aveni Casucci MA; Pedrazzi F; Ponari O; Capodaglio M; Valdina P; Toxiri I; Bartorelli L; Granata Q; Franzini C
J Int Med Res; 1992 Apr; 20(2):136-49. PubMed ID: 1521670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
